Skip to main content
. Author manuscript; available in PMC: 2017 May 17.
Published in final edited form as: Ann Intern Med. 2016 Mar 22;164(10):649–655. doi: 10.7326/M15-0964

Figure 1.

Figure 1

Prevalence of breast biopsy diagnostic interpretations in the B-Path Study test set and among women aged 50 to 59 y having screening mammography in the United States.

Estimates of population prevalence are from the Breast Cancer Surveillance Consortium (6). B-Path = Breast Pathology; DCIS = ductal carcinoma in situ.